InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Explore the complete record of transactions filed by Grewal Harpreet, Director. Officer active across 1 companies, notably Penumbra Inc. In total, 7 disclosures have been published. Total volume traded: €947k. The latest transaction was disclosed on 18 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
0710 shares0
Common Stock
SEC:0001321732-22-000020:0·
€159,059634 shares@ €250.88230.0013% mcap33.6% of flow
Common Stock
SEC:0001321732-22-000004·
€159,059634 shares@ €250.88230.0013% mcap16.8% of flow
Common Stock
SEC:0001321732-22-000004:0·
€146,284634 shares@ €230.73180.0012% mcap30.9% of flow
Common Stock
SEC:0001321732-21-000090·
€146,284634 shares@ €230.73180.0012% mcap15.4% of flow
Common Stock
SEC:0001321732-21-000090:0·
€168,096732 shares@ €229.63890.0013% mcap35.5% of flow
Common Stock
SEC:0001321732-21-000072·
€168,096732 shares@ €229.63890.0013% mcap17.8% of flow
Common Stock
SEC:0001321732-21-000072:0·
7 of 7 declarations
About Grewal Harpreet
Harpreet Grewal is a Director at Penumbra Inc. He participates in the governance of the company and contributes to strategic decision-making. His experience in the medical device sector allows him to provide valuable insights to the board.
